Short- and Long-Term Effectiveness of Supplementation with Non-Animal Chondroitin Sulphate on Inflammation, Oxidative Stress and Functional Status in Obese Subjects with Moderate Knee Osteoarthritis before and after Physical Stress: A Randomized, Double-Blind, Placebo-Controlled Trial.
inflammation
knee osteoarthritis
nonanimal chondroitin sulfate
obesity
overweight
pain
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
07 Dec 2020
07 Dec 2020
Historique:
received:
14
09
2020
revised:
25
11
2020
accepted:
27
11
2020
entrez:
10
12
2020
pubmed:
11
12
2020
medline:
11
12
2020
Statut:
epublish
Résumé
It has recently been demonstrated that chronic supplementation with nonanimal chondroitin sulfate (nonanimal CS) in overweight subjects with knee osteoarthritis (OA) improves the function, pain and inflammation, but there are no studies of its effectiveness in an acute setting. In 48 obese subjects with moderate knee OA, we investigated the effectiveness of nonanimal CS supplementation for eight weeks on the inflammation, functional status, oxidative stress, cartilage catabolism markers, metabolic profile and body composition, by Dual-Energy X-ray Absorptiometry (DXA) at the baseline, after 15 days and at the end of the eight-week study. To evaluate the acute effectiveness on inflammation, 15-min cycle training sessions were done 15 days after the start of the study and at the end. C-reactive protein (CRP) was assayed in blood samples collected before and after the two cycling exercises. The 48 obese subjects (M and F, 20-50 years, body mass index (BMI) 30-35 kg/m
Identifiants
pubmed: 33297347
pii: antiox9121241
doi: 10.3390/antiox9121241
pmc: PMC7762287
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cell Biol Int. 2006 Jan;30(1):21-30
pubmed: 16275145
Methods Enzymol. 1997;281:43-53
pubmed: 9250965
J Med Biochem. 2017 Apr 22;36(2):107-112
pubmed: 28680353
Ann Rheum Dis. 2013 Jul;72(7):1125-35
pubmed: 23595142
Nutrients. 2020 May 03;12(5):
pubmed: 32375231
Osteoarthritis Cartilage. 2003 Jun;11(6):433-41
pubmed: 12801483
Osteoarthritis Cartilage. 2015 Apr;23(4):507-15
pubmed: 25447976
Osteoarthritis Cartilage. 2003 Aug;11(8):551-60
pubmed: 12880577
Mol Neurobiol. 2016 Jan;53(1):73-82
pubmed: 25404091
PLoS One. 2017 Jun 5;12(6):e0178900
pubmed: 28582461
Eur J Appl Physiol. 2013 Jun;113(6):1635-42
pubmed: 23361845
FASEB J. 2002 Sep;16(11):1335-47
pubmed: 12205025
J Pharm Sci. 2007 Dec;96(12):3168-80
pubmed: 17630645
Arthritis Rheumatol. 2016 Aug;68(8):1869-75
pubmed: 27059260
Curr Drug Targets Immune Endocr Metabol Disord. 2004 Jun;4(2):119-27
pubmed: 15180452
Orthopedics. 2018 Jul 1;41(4):200-207
pubmed: 29771395
Ann Rheum Dis. 2003 Dec;62(12):1145-55
pubmed: 14644851
Arch Pharm Res. 2004 Aug;27(8):867-72
pubmed: 15460450
Neurochem Res. 2015 Jul;40(7):1509-19
pubmed: 26033682
Diabetes Care. 1996 Oct;19(10):1138-41
pubmed: 8886564
Nutrients. 2019 Aug 29;11(9):
pubmed: 31470599
Nutr J. 2016 Jan 05;15:1
pubmed: 26728196
Nutr Diabetes. 2017 Jan 9;7(1):e238
pubmed: 28067890
Clin Biochem. 2017 Jul;50(10-11):568-573
pubmed: 28242283
Maturitas. 2014 Jul;78(3):184-7
pubmed: 24861964
Adv Pharmacol. 2006;53:417-31
pubmed: 17239778
Ann Rheum Dis. 2007 Mar;66(3):377-88
pubmed: 17046965
Cochrane Database Syst Rev. 2015 Jan 28;1:CD005614
pubmed: 25629804
Exp Ther Med. 2011 Sep;2(5):893-899
pubmed: 22977594
Int J Obes Relat Metab Disord. 2000 Sep;24(9):1131-8
pubmed: 11033981
Carbohydr Polym. 2019 Jun 15;214:303-310
pubmed: 30926001
Rheumatol Int. 2018 Aug;38(8):1413-1428
pubmed: 29947998